Hepatitis E Virus Entry

被引:30
|
作者
Yin, Xin [1 ,3 ]
Feng, Zongdi [1 ,2 ]
机构
[1] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
[3] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, Immun & Pathogenesis Program, La Jolla, CA 92037 USA
来源
VIRUSES-BASEL | 2019年 / 11卷 / 10期
关键词
quasienveloped virus; receptor; lysosomal acid lipase; NPC1; RIBAVIRIN TREATMENT FAILURE; ENTERS LIVER-CELLS; ORF3; PROTEIN; VIRAL-HEPATITIS; CULTURED-CELLS; HEV; INFECTION; PATHOGENESIS; REPLICATION; INTERACTS;
D O I
10.3390/v11100883
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis E virus (HEV) infection is a major cause of acute hepatitis worldwide. It is transmitted enterically but replicates in the liver. Recent studies indicate that HEV exists in two forms: naked, nonenveloped virions that are shed into feces to mediate inter-host transmission, and membrane-cloaked, quasienveloped virions that circulate in the bloodstream to mediate virus spread within a host. Both virion types are infectious, but differ in the way they infect cells. Elucidating the entry mechanism for both virion types is essential to understand HEV biology and pathogenesis, and is relevant to the development of treatments and preventions for HEV. This review summarizes the current understanding of the cell entry mechanism for these two HEV virion types.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cellular Organelles Involved in Hepatitis E Virus Infection
    Liu, Xing
    Wang, Menghang
    Yin, Xin
    PATHOGENS, 2021, 10 (09):
  • [42] Antiviral Candidates for Treating Hepatitis E Virus Infection
    Netzler, Natalie E.
    Tuipulotu, Daniel Enosi
    Vasudevan, Subhash G.
    Mackenzie, Jason M.
    White, Peter A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
  • [43] ATP5B Is an Essential Factor for Hepatitis B Virus Entry
    Ueda, Keiji
    Suwanmanee, Yadarat
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [44] Genotype-Specific Evolution of Hepatitis E Virus
    Brayne, Adam B.
    Dearlove, Bethany L.
    Lester, James S.
    Pond, Sergei L. Kosakovsky
    Frost, Simon D. W.
    JOURNAL OF VIROLOGY, 2017, 91 (09)
  • [45] Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections
    Walker, Christopher M.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (09):
  • [46] On the Host Side of the Hepatitis E Virus Life Cycle
    Oechslin, Noemie
    Moradpour, Darius
    Gouttenoire, Jerome
    CELLS, 2020, 9 (05)
  • [47] Hepatitis E virus neutralization by porcine serum antibodies
    Gremmel, Nele
    Keuling, Oliver
    Eiden, Martin
    Groschup, Martin H.
    Johne, Reimar
    Becher, Paul
    Baechlein, Christine
    JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (11)
  • [48] Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses
    Yin, Xin
    Ambardekar, Charuta
    Lu, Yurong
    Feng, Zongdi
    JOURNAL OF VIROLOGY, 2016, 90 (08) : 4232 - 4242
  • [49] First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
    Blank, Antje
    Markert, Christoph
    Hohmann, Nicolas
    Carls, Alexandra
    Mikus, Gerd
    Lehr, Thorsten
    Alexandrov, Alexander
    Haag, Mathias
    Schwab, Matthias
    Urban, Stephan
    Haefeli, Walter E.
    JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 483 - 489
  • [50] Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands
    Tholen, Aletta T. R.
    Schinkel, Janke
    Molenkamp, Richard
    Ang, C. Wim
    PLOS ONE, 2016, 11 (02):